News Release

 View printer-friendly version

Charles River Laboratories Announces Intention to File a Registration Statement

WILMINGTON, Mass.--(BW HealthWire)--June 22, 2001--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to file a registration statement with the Securities and Exchange Commission on June 25, 2001 for a proposed underwritten offering of 8,000,000 shares of its common stock, plus an additional 1,200,000 shares to cover over-allotments if the underwriters exercise the over-allotment option. The Company will sell 2,000,000 shares and selling shareholders will sell the remaining 6,000,000 shares and the 1,200,000 over-allotment shares, if any.

This release is not an offer to sell or a solicitation of an offer to buy any of these securities.

--30--kc/bos*

CONTACT: Charles River Laboratories International, Inc.
Dennis Shaughnessy
978/658-6000 x.1207


Featured Report

Charles River Corporate Citizenship Report
View PDF
Print PDF